Skip to main content
Suphamai Bunnapradist, MD, Nephrology, Los Angeles, CA

SuphamaiBunnapradistMD

Nephrology Los Angeles, CA

Kidney & Pancreas Transplantation

Professor, Medicine, UCLA School of Medicine

Dr. Bunnapradist is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bunnapradist's full profile

Already have an account?

  • Office

    200 UCLA Medical Plz Ste 565c
    Los Angeles, CA 90095
    Phone+1 310-267-2555
    Fax+1 310-206-3607

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 1998 - 1999
  • Tufts Medical Center
    Tufts Medical CenterFellowship, Nephrology, 1996 - 1998
  • Columbus Hospital
    Columbus HospitalResidency, Internal Medicine, 1993 - 1996
  • Chulalongkorn University Faculty of Medicine
    Chulalongkorn University Faculty of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2026
  • IL State Medical License
    IL State Medical License 1995 - 1996
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect Conference
    Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
  • Natera Announces Data from the ProActive Study That Supports Prospera(TM) Kidney as an Early Indicator of Transplant Rejection
    Natera Announces Data from the ProActive Study That Supports Prospera(TM) Kidney as an Early Indicator of Transplant RejectionJune 6th, 2023